Home/Anebulo Pharmaceuticals/Daniel George

DG

Daniel George

Acting Chief Financial Officer

Anebulo Pharmaceuticals

Therapeutic Areas

Acute Cannabinoid Intoxication Substance Use Disorders

Anebulo Pharmaceuticals Pipeline

Drug	Indication	Phase
ANEB-001	Acute Cannabinoid Intoxication / Unintentional Cannabis Poisoning	Phase 2

Leadership Team at Anebulo Pharmaceuticals

Richie Cunningham

Chief Executive Officer

Dr. Kenneth Cundy, Ph.D.

Chief Scientific Officer

View full Anebulo Pharmaceuticals profile